CA2351616A1 - Purification method and apparatus - Google Patents
Purification method and apparatus Download PDFInfo
- Publication number
- CA2351616A1 CA2351616A1 CA002351616A CA2351616A CA2351616A1 CA 2351616 A1 CA2351616 A1 CA 2351616A1 CA 002351616 A CA002351616 A CA 002351616A CA 2351616 A CA2351616 A CA 2351616A CA 2351616 A1 CA2351616 A1 CA 2351616A1
- Authority
- CA
- Canada
- Prior art keywords
- sample collection
- collection assembly
- reservoir tube
- wand
- cap
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/34—Purifying; Cleaning
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/02—Devices for withdrawing samples
- G01N2001/028—Sampling from a surface, swabbing, vaporising
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/2813—Producing thin layers of samples on a substrate, e.g. smearing, spinning-on
- G01N2001/2826—Collecting by adsorption or absorption
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Abstract
A purification apparatus (1), kit and method for purifying DNA, RNA, proteins, antigens, antibodies and cells. The apparatus (1) has a wand (2) and a reservoir tube (6). The wand (2) is made of a cap (5), a sample collection assembly (4) and an elongated shaft (3) connecting the cap (5) to the sample collection assembly (4). The sample collection (4) assembly has a series of microstructures (13) on its surface, or microparticles enclosed within it for increasing the surface area of the sample collection assembly (4). The increased surface area permits maximum exposure to and binding of target molecules thereto. The reservoir tube (6) associated with the wand (2) has one end defining an opening and a second end that is closed and preferably cone or cylindrical shaped. The cap (5) of the wand securely and sealingly fastens to the open end of the reservoir tube (6) with the shaft (3) and the sample collection (4) assembly fitting easily inside the reservoir tube.
Description
U.S. Patent Application of IBRAHIM
PURIFICATION METHOD AND APPARATUS
1. Field of the invention This invention relates to a method, an apparatus, and kit for performing purification of nucleic acids, proteins and cells. More specifically, the invention relates to an apparatus and methods for purification and concentration of nucleic acids, proteins (e.g., antigens and antibodies) and cells without the need of centrifugation, precipitation or lengthy incubations. The apparatus and methods can be adapted to non-specific or specific capture of nucleic acids, proteins or cells in a biological or environmental samples and can be adapted for detection of the captured moiety by enzymatic colorimetric, fluorescent, luminescent or electrochemical formats with or without nucleic acids amplification.
PURIFICATION METHOD AND APPARATUS
1. Field of the invention This invention relates to a method, an apparatus, and kit for performing purification of nucleic acids, proteins and cells. More specifically, the invention relates to an apparatus and methods for purification and concentration of nucleic acids, proteins (e.g., antigens and antibodies) and cells without the need of centrifugation, precipitation or lengthy incubations. The apparatus and methods can be adapted to non-specific or specific capture of nucleic acids, proteins or cells in a biological or environmental samples and can be adapted for detection of the captured moiety by enzymatic colorimetric, fluorescent, luminescent or electrochemical formats with or without nucleic acids amplification.
2. Descr'~gtion of Related Art Nucleic acids preparation and purification is essential to virtually all molecular biology. Most methods in use for purifying nucleic acids rely on labor-intensive organic extractions and/or centrifugation. In recent years, a new class of analytical and purification techniques have been developed which rely on the inherent biological affinities between proteins, between enzymes and their substrates, and between proteins and nucleic acids.
Affinity techniques are attractive because the desired molecules are rapidly and specifically immobilized away from the other contaminating molecules in an impure mixture, offering rapid and extensive purification or enrichment levels.
Contaminating molecules are simply washed away, while target molecules remain firmly affinity-bound.
Target molecules may be detached from their counterpart molecules simply by altering the environment to disfavor the affinity between the two.
In one technique, a solid phase support is used to attach target molecules from a sample, such as DNA, RNA, proteins or cells. The solid phase support can also be coated U.S. Patent Application of IBRAHIM
with specific oligonucleotides, peptide or cell receptors to capture a specific DNA, RNA
or protein molecules as well as whole cells or microorganisms. Such solid phase supports consist generally of material with selective adsorption, ion exchange and catalytic properties. When such solid phase supports are formed by deep reactive ion etching (DRIE), they can provide exceptionally large surface area, high levels of activity and selectivity in a wide range of reactions, for example to nonspecifically capture electrically charged molecules, or specifically capture molecules through affinity binding.
Examples of solid phase supports include silica-based material, synthetic polymers and a host of other naturally-occurring or chemically modified elements.
Chemical modification may be achieved by incorporating metal atoms, e.g., Li, Be, Mg, Co, Fe, Mn, Zn, B, Ga, Fe, Ge, Ti, Au, Pt or As into a solid support framework consisting of, for example, Si4+ and A13+. In a typical application of a solid support system to directly capture nucleic acids molecules, for example, is to mix a biological sample with a guanidine-based lysis/binding solution in the reservoir, the sample capture assembly is inserted into the reservoir, sealed, the entire apparatus is briefly vortexed, agitated or sonicated, briefly incubated at the appropriate temperature, e.g., 37°C (the shaft may also be thermally regulated through an attachment to a miniaturized thermal regulator) to allow the released nucleic acids to adsorb or bind to the capture assembly.
Mechanical disruption (by vortexing, sonication or shaking) or enzymatic disruption (e.g., by lysozymes, proteinase K, collagenase) may be required for some biological samples to enhance the release of nucleic acids.
After the nucleic acids are released and captured onto the capture assembly by virtue of electrical charge or affinity binding, the capture assembly is removed, placed into another reservoir containing wash buffer with appropriate salt concentration and ionic strength (e.g., 1.0 M NaCI, 50 mM MOPS, 15% ethanol, pH 7.0 for DNA), sealed and briefly vortexed or agitated. Several washes can be performed in the same reservoir by replenishing the wash buffer if multiple washing is necessary to remove undesirable or inhibitory material from the captures nucleic acids. The removal of undesirable or inhibitory material can enhance subsequent nucleic acids amplification steps.
After washing, the reservoir is replaced with a fresh reservoir containing elution buffer with appropriate salt concentration and ionic strength (e.g., 1.25 M
NaCI, 50 mM
U.S. Patent Application of IBRAHIM
Tris/HCI, 15 % ethanol, pH 8.5 for DNA), and the capture assembly is inserted into the reservoir, incubated at the appropriate temperature, e.g., 65°C for several minutes (or the capture assembly is subjected to the appropriate elution temperature through the thermal regulator attachment). Alternatively, it is possible to perform thermal cycling through the thermal regulator attachment while the DNA is initially bound to the capture assembly with the appropriate nucleic acids amplification buffer and reagents placed in the reservoir. The Lysis/binding, washing and elution buffer conditions may be adapted according to the sample type and the type of the nucleic acids (DNA or RNA).
However, the solid phase supports currently available do not provide vast surface area to maximize binding of molecules. In addition, they are expensive to make, and do not lend themselves to in-home or field use because of either their size or configuration.
Furthermore, they do not allow the flexibility of purifying different types of molecules, e.g., nucleic acids, proteins or whole cells in a single format with the ability to capture such molecules specifically or nonspecifically, and detect such molecules (specially nucleic acids) with or without nucleic acids amplification using colorimetric, fluorescent, luminescent or electrochemical formats. The present invention, in toto, allows much greater flexibility and efficiency and is adaptable to future modification by, for example, incorporating thermal cycling amplification (e.g. PCR), isothermal amplification and fluorogenic, colorimetric, luminescence or electrochemical detection in the same device.
The present invention also allows incorporation of specific capture molecules, e.g.
dendritic (branched) oligonucleotides or peptides to further increase the capture surface area and allow the specific capture of nucleic acids, cells or proteins. In addition, the invention can be adapted to an arrayable platform to allow high throughput sample processing and detection in the same device.
What is lacking in the art is a simple, inexpensive apparatus, flexible kit and method for DNA, RNA, protein, antigen, antibody or cell purification that can be used in the field, home or laboratory with the flexibility described above. In particular, what is needed is an apparatus and method that does not require centrifugation, precipitation, lengthy incubations, or extensive equipment and that provides a massive surface area for maximum exposure to and binding of target molecules. With an increasing desire to perform rapid testing for a variety of infectious disease agents or biological markers in U.S. Patent Application of IBRAHIM
the home, field or by medical and health care workers, there is a need to provide a simple, flexible and easy to use apparatus, kit and methods for purification and detection.
It is therefore an object of the invention to provide a simple method, apparatus and kit for conducting DNA, RNA, protein or cell purification.
It is a further object of the invention to provide an apparatus that is convenient to use in the home or in the field that provides high precision and good economy.
It is still a further object of the invention to provide an apparatus that provides efficient purification of nucleic acids, proteins, or cells with out the need for centrifugation, precipitation or lengthy incubations.
It is a further object of this invention to provide an apparatus that is adaptable for direct detection of nucleic acids and proteins by colorimetric, fluorogenic, luminescence or electronic means or detection of nucleic acids molecules after nucleic acids amplification in such an apparatus.
It is a further object of this invention to provide an apparatus and concept that is a adaptable for rapid, flexible high through put screening of biological samples or biological products for infectious disease agents and biomarkers.
These and other objects are achieved with the method, apparatus and kit of the present invention.
The present invention is summarized as an apparatus for purifying DNA, RNA, proteins (antigens and antibodies) or cells and is adaptable for detection of such moieties by a variety of detection formats with a wide range of applications in the medical diagnostics, counter bioterrorism and the health care arena. The apparatus has a wand and a reservoir tube (e.g., a microfuge tube). The wand is made of a cap, a sample collection assembly and an elongated shaft connecting the cap to the sample collection assembly. The sample collection assembly has a series of microstructures on its surface or microparticles enclosed within it for increasing the surface area of the sample collection assembly. The increased surface area permits maximum exposure to and binding of target molecules thereto.
U.S. Patent Application of IBRAHIM
The reservoir tube associated with the wand has one end defining an opening and a second end that is closed. The cap of the wand securely and sealingly fastens to the open end of the reservoir tube with the shaft and the sample collection assembly fitting easily inside the reservoir tube.
In use, for nucleic acids applications, a sample is placed inside a first reservoir tube with a lysis or denaturing solution. Then the wand is inserted into the first reservoir tube. The cap of the wand secures and seals closed the first reservoir tube.
The first reservoir tube is agitated by shaking or vortexing to mix the sample with the denaturing solution. During this step, the target molecules bind to the sample collection assembly's massive surface area. The wand, which now has target molecules attached to the sample collection assembly is then removed from the first reservoir tube and inserted into a second reservoir tube which contains a wash buffer.
The second reservoir tube is then securely and sealingly closed with the cap of the wand like before. The second reservoir tube is also agitated to mix the sample with the wash buffer. The wand is then removed from the second reservoir tube and inserted into a third reservoir tube. The third reservoir tube contains an elution buffer.
The third reservoir tube; is incubated and after a short while, the DNA or RNA
is purified. It can then be recovered and analysed.
A similar process is used for the capture of antigens, antibodies or cells, however different reagents or buffers are used.
Agitation or sealing is not required during the incubation steps as long as the capture assembly is in contact with the sample. However, agitation may enhance binding and sealing would help contain the sample in the reservoir and prevent accidental loss of the sample or contaminating the sample from an outside source.
FIG. 1 is a perspective view of a Purification Apparatus according to a first embodiment of the invention;
U.S. Patent Application of IBRAHIM
FIG. la is an enlargement of the flange 12 shown in FIG. 1;
FIG. 2 is a perspective view of a Purification Apparatus according to a second embodiment of the invention;
FIG. 3 is a perspective view of a Purification Apparatus according to a third embodiment of the invention;
FIG. 4 is perspective view a screw on cap;
FIG. S is a perspective view of a snap-on cap; and FIG. 6 is a perspective view of a Purification Apparatus according to the invention showing a heating unit and a sensing unit.
The present invention is directed to a purification apparatus for purifying Nucleic acids, proteins, microorganisms or cells.
Refernng to Fig. 1, the purification apparatus 1 has a wand 2 and a reservoir tube 6. The wand 1 is made of a cap 5, a sample collection assembly 4 and an elongated shaft 3 connecting the cap 5 to the sample collection assembly 4. The sample collection assembly 4 has a series of microstructures 13 in the form of grooves (created by deep reactive ion etching or tooling), parallel lanes or cross-etchings on its surface, or microparticles 13a (See Fig. 2) enclosed within it for increasing the surface area of the sample collection assembly 4. The increased surface area permits maximum exposure to and binding of target molecules thereto, allowing concentration of target molecules or cells.
The cap 5 of the wand 1 is easily held between the forefinger and the thumb of a user. The cap configuration reduces the risk of contamination because the user's fingers do not come into contact with the sample capture assembly. The cap fits snugly into the open end 9 at the lip 10 of the reservoir tube 6. Referring to Figs. 4 and 5, the cap 5 can be formed with screw-on ridges 15 for screwing the cap S into the reservoir tube 6. In this embodiment, the reservoir tube has complimentary grooves (not shown) therein for receiving a screw-on cap in a sealing engagement. Alternatively, the cap 5 can have a stopper lip 16 and can fit into the reservoir tube 6 and be held in place in a sealed fashion by the force of friction or by a ridge 18 with a complimentary groove (not shown) inside U.S. Patent Application of IBRAHIM
the reservoir tube for receiving the ridge 18. A tab 17 assists the user in removing the wand from the reservoir tube 6 as shown in Fig. 5.
The cap 5 is connected to one end of a shaft 3. The other end of the shaft is connected to a sample capture assembly 4. The shaft 3 is either solid or hollow and can be formed of metal or an inert synthetic material such as plastic. The sample capture assembly 4 is designed to increase surface area to a maximum to allow maximum exposure to and binding of target molecules thereto. Therefore, the sample capture assembly 4 has microstructures associated therewith, either on its surface or within it in the form of microparticles enclosed inside a mesh enclosure in a form of a "molecular sieve". If microparticles are used, further enhancements, e.g., the use of zeolitic particles, can be made to allow molecular size selection.
The sample capture assembly 4 is generally a main body 11 having microstructures on its surface in the form of cross-etched lanes, dimples, domes, pillars and/or pores. Such microstructures can be formed by tooling or etching.
Preferably, cross-etched lanes in the configuration presented herein are used as microstructures and are etched to a depth of 0.001-2 mm and preferably 2 mm. The main body 11 can preferably have one or more flanges 12 protruding radially outward therefrom, wherein the microstructures 13 are on an outer surface of the flanges 12. Fig. la shows an enlargement of a single flangel2. Alternatively, the main body can have striations 14, wherein a cross-section of the main body 11 would reveal a jagged outer edge as shown in Fig. 3. The striations increase the surface area and preferably also have microstructures on their outer surface. The main body 11 can also be porous.
Still further, Fig. 2 shows a wand 2 having a sample capture assembly 4 that has microstructures 13a associated therewith within it in the form of microparticles enclosed inside a mesh enclosure 13b. The microparticles are made from silica-based material, polystyrene or other synthetic polymers and may be coated with a target specific surface such as specific oligonucleotides, peptides or cell receptors to capture a target DNA, RNA, protein or cell type. They are preferably about 1 to SOO~tm in diameter.
The sample collection assembly 4 may be coated with oligonucleotide probes or specific proteins to capture specific target molecules. The sample collection assembly may also be made of or coated with a material that binds non-specifically with nucleic U.S. Patent Application of IBRAHIM
acids or proteins. A suitable material for binding non-specifically to nucleic acids include silica-based material and synthetic polymers. However, a host of other naturally occurring or chemically modified elements that are known to bind non-specifically to nucleic acids or proteins may be used. The sample collection assembly can also be coated with gold, platimum or other material to enhance electrical or electrochemical conductivity. The sample collection assembly can also be coated with singular or dendritic oligonucleotide probes, peptide probes or cell receptors to capture specific target molecules. The use of dendritic probes in conjunction with the sample collection assembly described herein can further significantly increase the capture surface area and significantly enhance analytical and clinical sensitivity.
The capture of nucleic acids, proteins or cells either non-specifically or by affinity binding onto solid phase supports as well as colorimetric, luminescent, fluorescent and electrochemical detection are well known in the art as described in the following and other references, of which these are herein incorporated by reference: Ausubel F., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., Struhl K., (1987).
Current Protocols in Molecular Biology. Greene Publishing Associates and Wiley-Intersciences.
John Wiley & Sons, New York, Chichester, Brisbane, Toronto, Singapore.;
Sambrook J., Fritsch EF, Maniatis J. ( 1989). Molecular cloning: A laboratory manual. 2"d edition, Cold Spring Harbor laboratory Press, Cold Spring Harbor, New York.; Hornes E., Korsnes L. ( 1990). Magnetic DNA hybridization properties of oligonucleotide probes attached to superparamagnetic beads and their use in the isolation of poly(A) mRNA
from eukaryotic cells. Genet. Anal. Tech. Appl. 7:145-150.; Jakobsen K.S., Haugen M., Saeboe-Larsen S., Hollung K., Espelund M., Hornes E. ( 1994). Direct mRNA
isolation using magnetic Oligo(dT) beads: A protocol for all types oc cell cultures, animal and plant tissues. In: Advances in Biomagnetic Separation, (Ed. Uhlen M., Hornes E., Olsvik O) Eaton Publishing pp.61-71.; Rodriguez LR., Chader G.J. (1992). A novel method for the isolation of tissue specific genes. Nucleic Acids Res. 18:4833-4842.;
Schussler P., Gohr L.G., Sommer G., Kunz W., Grevelding C.G. (1995). Combined isolation of nucleic acids and proteins from small amounts of tissue. Trends Genet. 11:378-379.;
Beattie K.L., Fowler R.F. (1991). Solid-phase gene assembly. Nature 352:548-552.;
Rudi K., Kroken M., Dahlberg O.J., Deggerdal A., Jakobsen K.S., Larsen F. ( 1997).
U.S. Patent Application of IBRAHIM
Rapid, universal method to isolate PCR-ready DNA using magnetic beads.
BioTechniques 22:506-511.; Collin-Osdoby P., Oursler M.J., Webber D., Osdoby P.
( 1991 ). Osteoclast-specific monoclonal antibodies coupled to magnetic beads provide a rapid and efficient method of purifying avian osteoclasts. J. Bone Mine. Res.
6:1353-1365.; Cudjoe K.S., Krona R., Olsen E. (1994). IMS: A new selective enrichment technique for the detection of salmonella in foods. Int. J. Food Microbiol.
23:159-165.;
Elgar G.S., Brenner S. (1992). A novel method for isolation of large insert DNA from recombinant lambda DNA. Nucleic Acids Res. 20:4667.; Gabrielsen O.S., Huet J.
(1993). Magnetic DNA affinity purification of yeast transcription factor.
Meth.
Enzymol. 218:508-525.; Hames B.D., Higgins S.J. (1985). Nucleic acid hybridization:
A practical approach. IRL Press, Oxford, England.; Hawkins R.E., Russell S.J., Winter G. ( 1992). Selection of phage antibodies by binding affinity. Mimicking affinity maturation. J. Mol. Biol. 226:889-896.; Boom, R., Sol, C.J., Salimans, M.M., Jansen, C.L., Wertheim-van Dillen, P.M., and van der Noordaa, J. (1990). Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol., 28(3):495-503.;
Lundeberg J., Larsen F. (1995). Solid-phase technology:magnetic beads to improve nucleic acid detection and analysis. Biotechnology Annual Review 1:373-401.; Millar D.S., Withey S.J., Tizard M.L.V., Ford J.G., Hermon-Taylor J. (1995). Solid-phase hybridization capture of low abundance target DNA sequences: application to the polymerase chain reaction detection of Mycobacterium paratuberculosis and Mycobacterium avium susp.
Silvaticum. Anal. Biochem. 226:325-330.; Vlieger A.M., Medenblik A.M.J.C., Van Gijlswijk R.P.M., Tanke H.J., Van der Ploeg M., Gratama J.W., Raap A.K.
(1992).
Quantitation of polymerase chain reaction products by hybridization-based assays with fluorescent, colorimetric or chemiluminescent detection. Anal. Biochem. 205:1-7.
The reservoir tube 6 serves as a reservoir for collecting samples, washing the captured nucleic acids, proteins, antibodies or antigens, and eluting the captured nucleic acid or proteins or other molecules. The reservoir tube 6 described herein has an elongated body 7 with one end having a lip 10 defining an opening 9 and a second end 8 that is closed and preferably cone shaped. The second end 8 can also be rounded or cylindrical. The cap S of the wand 2 securely and sealingly fastens to the open end 9 of the reservoir tube 6 with the shaft 3 and the sample collection assembly 4 fitting easily U.S. Patent Application of IBRAHIM
inside the reservoir tube 6. The reservoir tube typically holds 0.5-15 ml of sample and preferably is a 1.5 ml reservoir tube. The reservoir tube can be larger or smaller without detracting from the spirit of the invention. The reservoir can also be designed in the form of a microtiter plate or microtiter plate modules to allow arrayable, modular configuration.
The reservoir tube is made of a size to enclose the shaft and sample capture assembly of the wand and sealingly engage the wand's cap. The reservoir and wand can be manufactured together and be packaged as a kit with multiple reservoir (tubes of different sizes and shapes or microtiter plates) in each kit. The wand can be manufactured in a size to fit reservoirs of different sizes and shapes that are commercially sold on the market and commonly used in biomedical research.
In use, a sample is placed inside a first reservoir tube with a lysis or denaturing solution. By the term DNA or RNA sample, it is meant a sample, usually cells, that contain DNA or RNA within the cells. Then the wand is inserted into the first reservoir tube. The cap of the wand secures and seals closed the first reservoir tube.
The first reservoir tube is agitated by shaking or vortexing to mix the sample with the denaturing solution. The first tube is preferably incubated at 37°C for a period of 5-15 minutes. The shaft of the wand can be thermally regulated through an attachment or wire connection 22 to a heating unit 21 as shown in Fig. 6. During this step, the target molecules bind to the massive surface area of the sample collection assembly.
The wand, which now has target molecules bound to the sample collection assembly is then removed from the first reservoir tube and inserted into a second reservoir tube which contains a wash buffer. The second reservoir tube is then securely and sealingly closed with the cap of the wand as before. The second reservoir tube is also agitated to mix the sample with the wash buffer. One or several washes can be performed in the same reservoir if multiple washing is necessary to remove inhibitory material from the captured nucleic acids. The wand is then removed from the second reservoir tube and inserted into a third reservoir tube. The third reservoir tube contains an elution buffer. The third reservoir tube is incubated at about 65°C
for about 5-15 minutes with or without agitation or vortexing (agitation or vortexing may enhance elution). If the shaft is attached to a heating unit that regulates temperature in the sample to U.S. Patent Application of IBRAHIM
capture assembly, elution can be achieved by adjusting the incubation temperature.
After a short while, the DNA or RNA is purified. It can then be recovered and analyzed.
It is also possible to perform thermal cycling while the captured DNA is bound to the capture assembly, and the elution buffer is replaced with the appropriate nucleic acid amplification buffer and reagents.
The sample can be detected by one of several methods. DNA or amplified DNA
can be detected by known colorimetric, luminescent, fluorescent or electrochemical methods.
In another embodiment, the wand may further have a sensing unit 24 associated with it via a sensing contact or wire connection 25 as shown in FIG. 6 for sensing electrical or electrochemical signals emitted from the sample on the sample collection assembly, following a hybridization and/or an enzymatic reaction. Such a sensing unit would detect changes in electrical properties of bound nucleic acids or protein molecules either directly or indirectly. Direct detection can be achieved by measuring changes in current subsequent to a hybridization reaction. Indirect detection can be achieved by including in the hybridization reaction an enzyme and a substrate to drive a reduction/oxidation reaction resulting in electrical current change which can be measured by an electric current sensing device, for example. Alternatively, other indirect reaction may involve enzymatic reaction to produce colorimetric, fluorogenic or luminescence signal which can be detected with miniature optical devices such as a flurometer or spectrometer designed to fit the closed end of the reservoir. In this embodiment, the tube would fit into such a detection device wherein the detection would take place.
The purification apparatus of the invention can be used for efficient purification of nucleic acids, proteins and cells without the need of centrifugation, precipitation or lengthy incubations. It can also be configured to allow nucleic acid amplification and detection by integrating the purification apparatus into an instrument that allows temperature cycling and detection apparati capable of fluorescent, colorimetric, luminescent or electrochemical sensing.
EK~MPLES
Example 1 U.S. Patent Application of IBRAHIM
In a typical nucleic acids purification, mix 10-100 pl of sample with 100 p.l of lysis/denaturing buffer in a 1.5 ml reservoir tube. Insert the shaft and sample capture assembly of the wand into the reservoir tube and close the reservoir tube with the cap.
Vortex the reservoir tube for about 1 minute. Incubate the reservoir tube at 37°C for about 5 minutes. Remove the wand, and insert the wand into a fresh reservoir tube containing 1000 pl of wash buffer. Vortex the reservoir tube for about 1 minute.
Remove the wand and insert it into a fresh reservoir tube containing 100 pl of elution buffer. Heat the reservoir tube to abut 65°C for about 5 minutes. The DNA or RNA is now purified and ready for further analysis or processing.
Example 2 Detection of nucleic acids can be performed in a variety of formats. For example, after the captured nucleic acids are eluted into the reservoir, a biotin- and a digoxigenin-labeled probes can be hybridized, a streptavidin-coated capture assembly is immersed into the reservoir to capture they hybrid complex, then an antibody against digoxigenin is added to bind to the digoxigenin-labeled probe, then an enzyme labeled secondary antibody is added to bind to the primary antibody, then a chemiluminescent or colorimetric substrate is added to drive a colorimetric or luminescent reactions which can then be detected with a colorimeter, photoluminometer or by an electric current measuring device. A number of washing steps must be performed between the addition of reagents in the same or different reservoirs to remove unbound molecules.
These hybridization and detection methods are known in the art.
It is also possible to configure the detection assays so that the captured nucleic on the sample collection assembly is hybridized in situ to a tagged protein-DNA
probe and proceed with the detection according to methods that known in the art.
It is also possible to configure the detection assays so that fluorescently-labeled probes are used for hybridization and detection according to known methods.
Example 3 U.S. Patent Application of IBRAHIM
Mix 10-100 pl of sample with 100 ~tl of lysis/denaturing buffer in a 1.5 ml reservoir tube. Insert the shaft and sample capture assembly (after coating with appropriate antibody) of the wand into the reservoir tube and close the reservoir tube with the cap. Vortex the reservoir tube for about 1 minute. Incubate the reservoir tube at 37°C
for about 5-15 minutes. Remove the wand, and insert the wand into a fresh reservoir tube containing 1000 pl of blocking buffer. Vortex the reservoir tube for about 1 minute.
Incubate at 37°C for about S-15 minutes. Remove the wand and insert it into a fresh reservoir tube containing 100 p.l of conjugate solution. Remove the wand, and insert the wand into a fresh reservoir tube containing 1000 p.l of wash buffer. Shake or agitate for 1 min. Discard wash buffer and repeat the washing step. Remove the wand and insert it into a fresh reservoir tube containing 100 ltl of detection reagent. Analyze the color and determine the antigen according to a color chart. Alternatively, the color can be read by using a spectrophotometer. The detection step can also be modified to allow electrochemical, luminescent or fluorescent detection using an appropriate signal detection attachment.
Example 4 Mix 10-100 ~tl of sample with 100 ~1 of lysis/denaturing buffer in a 1.5 ml reservoir tube. Insert the shaft and sample capture assembly (after coating with appropriate antigen) of the wand into the reservoir tube and close the reservoir tube with the cap. Vortex the reservoir tube for about 1 minute. Incubate the reservoir tube at 37°C
for about 5-15 minutes. Remove the wand, and insert the wand into a fresh reservoir tube containing 1000 pl of blocking buffer. Vortex the reservoir tube for about 1 minute.
Incubate at 37°C for about S minutes. Remove the wand and insert it into a fresh reservoir tube containing 100 ltl of conjugate solution. Remove the wand, and insert the wand into a fresh reservoir tube containing 1000 pl of wash buffer. Discard the wash buffer and repeat the washing step. Remove the wand and insert it into a fresh reservoir tube containing 100 pl of detection reagent. Analyze the color and determine the antibody.
U.S. Patent Application of IBRAHIM
Alternatively, the color can be read by using a spectrophotometer. The detection step can also be modified to allow electrochemical, luminescent or fluorescent detection using an appropriate signal detection attachment.
The present purification apparatus also has applications in detection of blood chemistry, detection of chemokines and other disease markers and identification of microbial agents.
Having thus described in detail preferred embodiments of the present invention, it is to be understood that the invention defined by the appended claims is not to be limited by particular details set forth in the above description as many apparent variations thereof are possible without departing from the spirit or scope of the present invention.
Affinity techniques are attractive because the desired molecules are rapidly and specifically immobilized away from the other contaminating molecules in an impure mixture, offering rapid and extensive purification or enrichment levels.
Contaminating molecules are simply washed away, while target molecules remain firmly affinity-bound.
Target molecules may be detached from their counterpart molecules simply by altering the environment to disfavor the affinity between the two.
In one technique, a solid phase support is used to attach target molecules from a sample, such as DNA, RNA, proteins or cells. The solid phase support can also be coated U.S. Patent Application of IBRAHIM
with specific oligonucleotides, peptide or cell receptors to capture a specific DNA, RNA
or protein molecules as well as whole cells or microorganisms. Such solid phase supports consist generally of material with selective adsorption, ion exchange and catalytic properties. When such solid phase supports are formed by deep reactive ion etching (DRIE), they can provide exceptionally large surface area, high levels of activity and selectivity in a wide range of reactions, for example to nonspecifically capture electrically charged molecules, or specifically capture molecules through affinity binding.
Examples of solid phase supports include silica-based material, synthetic polymers and a host of other naturally-occurring or chemically modified elements.
Chemical modification may be achieved by incorporating metal atoms, e.g., Li, Be, Mg, Co, Fe, Mn, Zn, B, Ga, Fe, Ge, Ti, Au, Pt or As into a solid support framework consisting of, for example, Si4+ and A13+. In a typical application of a solid support system to directly capture nucleic acids molecules, for example, is to mix a biological sample with a guanidine-based lysis/binding solution in the reservoir, the sample capture assembly is inserted into the reservoir, sealed, the entire apparatus is briefly vortexed, agitated or sonicated, briefly incubated at the appropriate temperature, e.g., 37°C (the shaft may also be thermally regulated through an attachment to a miniaturized thermal regulator) to allow the released nucleic acids to adsorb or bind to the capture assembly.
Mechanical disruption (by vortexing, sonication or shaking) or enzymatic disruption (e.g., by lysozymes, proteinase K, collagenase) may be required for some biological samples to enhance the release of nucleic acids.
After the nucleic acids are released and captured onto the capture assembly by virtue of electrical charge or affinity binding, the capture assembly is removed, placed into another reservoir containing wash buffer with appropriate salt concentration and ionic strength (e.g., 1.0 M NaCI, 50 mM MOPS, 15% ethanol, pH 7.0 for DNA), sealed and briefly vortexed or agitated. Several washes can be performed in the same reservoir by replenishing the wash buffer if multiple washing is necessary to remove undesirable or inhibitory material from the captures nucleic acids. The removal of undesirable or inhibitory material can enhance subsequent nucleic acids amplification steps.
After washing, the reservoir is replaced with a fresh reservoir containing elution buffer with appropriate salt concentration and ionic strength (e.g., 1.25 M
NaCI, 50 mM
U.S. Patent Application of IBRAHIM
Tris/HCI, 15 % ethanol, pH 8.5 for DNA), and the capture assembly is inserted into the reservoir, incubated at the appropriate temperature, e.g., 65°C for several minutes (or the capture assembly is subjected to the appropriate elution temperature through the thermal regulator attachment). Alternatively, it is possible to perform thermal cycling through the thermal regulator attachment while the DNA is initially bound to the capture assembly with the appropriate nucleic acids amplification buffer and reagents placed in the reservoir. The Lysis/binding, washing and elution buffer conditions may be adapted according to the sample type and the type of the nucleic acids (DNA or RNA).
However, the solid phase supports currently available do not provide vast surface area to maximize binding of molecules. In addition, they are expensive to make, and do not lend themselves to in-home or field use because of either their size or configuration.
Furthermore, they do not allow the flexibility of purifying different types of molecules, e.g., nucleic acids, proteins or whole cells in a single format with the ability to capture such molecules specifically or nonspecifically, and detect such molecules (specially nucleic acids) with or without nucleic acids amplification using colorimetric, fluorescent, luminescent or electrochemical formats. The present invention, in toto, allows much greater flexibility and efficiency and is adaptable to future modification by, for example, incorporating thermal cycling amplification (e.g. PCR), isothermal amplification and fluorogenic, colorimetric, luminescence or electrochemical detection in the same device.
The present invention also allows incorporation of specific capture molecules, e.g.
dendritic (branched) oligonucleotides or peptides to further increase the capture surface area and allow the specific capture of nucleic acids, cells or proteins. In addition, the invention can be adapted to an arrayable platform to allow high throughput sample processing and detection in the same device.
What is lacking in the art is a simple, inexpensive apparatus, flexible kit and method for DNA, RNA, protein, antigen, antibody or cell purification that can be used in the field, home or laboratory with the flexibility described above. In particular, what is needed is an apparatus and method that does not require centrifugation, precipitation, lengthy incubations, or extensive equipment and that provides a massive surface area for maximum exposure to and binding of target molecules. With an increasing desire to perform rapid testing for a variety of infectious disease agents or biological markers in U.S. Patent Application of IBRAHIM
the home, field or by medical and health care workers, there is a need to provide a simple, flexible and easy to use apparatus, kit and methods for purification and detection.
It is therefore an object of the invention to provide a simple method, apparatus and kit for conducting DNA, RNA, protein or cell purification.
It is a further object of the invention to provide an apparatus that is convenient to use in the home or in the field that provides high precision and good economy.
It is still a further object of the invention to provide an apparatus that provides efficient purification of nucleic acids, proteins, or cells with out the need for centrifugation, precipitation or lengthy incubations.
It is a further object of this invention to provide an apparatus that is adaptable for direct detection of nucleic acids and proteins by colorimetric, fluorogenic, luminescence or electronic means or detection of nucleic acids molecules after nucleic acids amplification in such an apparatus.
It is a further object of this invention to provide an apparatus and concept that is a adaptable for rapid, flexible high through put screening of biological samples or biological products for infectious disease agents and biomarkers.
These and other objects are achieved with the method, apparatus and kit of the present invention.
The present invention is summarized as an apparatus for purifying DNA, RNA, proteins (antigens and antibodies) or cells and is adaptable for detection of such moieties by a variety of detection formats with a wide range of applications in the medical diagnostics, counter bioterrorism and the health care arena. The apparatus has a wand and a reservoir tube (e.g., a microfuge tube). The wand is made of a cap, a sample collection assembly and an elongated shaft connecting the cap to the sample collection assembly. The sample collection assembly has a series of microstructures on its surface or microparticles enclosed within it for increasing the surface area of the sample collection assembly. The increased surface area permits maximum exposure to and binding of target molecules thereto.
U.S. Patent Application of IBRAHIM
The reservoir tube associated with the wand has one end defining an opening and a second end that is closed. The cap of the wand securely and sealingly fastens to the open end of the reservoir tube with the shaft and the sample collection assembly fitting easily inside the reservoir tube.
In use, for nucleic acids applications, a sample is placed inside a first reservoir tube with a lysis or denaturing solution. Then the wand is inserted into the first reservoir tube. The cap of the wand secures and seals closed the first reservoir tube.
The first reservoir tube is agitated by shaking or vortexing to mix the sample with the denaturing solution. During this step, the target molecules bind to the sample collection assembly's massive surface area. The wand, which now has target molecules attached to the sample collection assembly is then removed from the first reservoir tube and inserted into a second reservoir tube which contains a wash buffer.
The second reservoir tube is then securely and sealingly closed with the cap of the wand like before. The second reservoir tube is also agitated to mix the sample with the wash buffer. The wand is then removed from the second reservoir tube and inserted into a third reservoir tube. The third reservoir tube contains an elution buffer.
The third reservoir tube; is incubated and after a short while, the DNA or RNA
is purified. It can then be recovered and analysed.
A similar process is used for the capture of antigens, antibodies or cells, however different reagents or buffers are used.
Agitation or sealing is not required during the incubation steps as long as the capture assembly is in contact with the sample. However, agitation may enhance binding and sealing would help contain the sample in the reservoir and prevent accidental loss of the sample or contaminating the sample from an outside source.
FIG. 1 is a perspective view of a Purification Apparatus according to a first embodiment of the invention;
U.S. Patent Application of IBRAHIM
FIG. la is an enlargement of the flange 12 shown in FIG. 1;
FIG. 2 is a perspective view of a Purification Apparatus according to a second embodiment of the invention;
FIG. 3 is a perspective view of a Purification Apparatus according to a third embodiment of the invention;
FIG. 4 is perspective view a screw on cap;
FIG. S is a perspective view of a snap-on cap; and FIG. 6 is a perspective view of a Purification Apparatus according to the invention showing a heating unit and a sensing unit.
The present invention is directed to a purification apparatus for purifying Nucleic acids, proteins, microorganisms or cells.
Refernng to Fig. 1, the purification apparatus 1 has a wand 2 and a reservoir tube 6. The wand 1 is made of a cap 5, a sample collection assembly 4 and an elongated shaft 3 connecting the cap 5 to the sample collection assembly 4. The sample collection assembly 4 has a series of microstructures 13 in the form of grooves (created by deep reactive ion etching or tooling), parallel lanes or cross-etchings on its surface, or microparticles 13a (See Fig. 2) enclosed within it for increasing the surface area of the sample collection assembly 4. The increased surface area permits maximum exposure to and binding of target molecules thereto, allowing concentration of target molecules or cells.
The cap 5 of the wand 1 is easily held between the forefinger and the thumb of a user. The cap configuration reduces the risk of contamination because the user's fingers do not come into contact with the sample capture assembly. The cap fits snugly into the open end 9 at the lip 10 of the reservoir tube 6. Referring to Figs. 4 and 5, the cap 5 can be formed with screw-on ridges 15 for screwing the cap S into the reservoir tube 6. In this embodiment, the reservoir tube has complimentary grooves (not shown) therein for receiving a screw-on cap in a sealing engagement. Alternatively, the cap 5 can have a stopper lip 16 and can fit into the reservoir tube 6 and be held in place in a sealed fashion by the force of friction or by a ridge 18 with a complimentary groove (not shown) inside U.S. Patent Application of IBRAHIM
the reservoir tube for receiving the ridge 18. A tab 17 assists the user in removing the wand from the reservoir tube 6 as shown in Fig. 5.
The cap 5 is connected to one end of a shaft 3. The other end of the shaft is connected to a sample capture assembly 4. The shaft 3 is either solid or hollow and can be formed of metal or an inert synthetic material such as plastic. The sample capture assembly 4 is designed to increase surface area to a maximum to allow maximum exposure to and binding of target molecules thereto. Therefore, the sample capture assembly 4 has microstructures associated therewith, either on its surface or within it in the form of microparticles enclosed inside a mesh enclosure in a form of a "molecular sieve". If microparticles are used, further enhancements, e.g., the use of zeolitic particles, can be made to allow molecular size selection.
The sample capture assembly 4 is generally a main body 11 having microstructures on its surface in the form of cross-etched lanes, dimples, domes, pillars and/or pores. Such microstructures can be formed by tooling or etching.
Preferably, cross-etched lanes in the configuration presented herein are used as microstructures and are etched to a depth of 0.001-2 mm and preferably 2 mm. The main body 11 can preferably have one or more flanges 12 protruding radially outward therefrom, wherein the microstructures 13 are on an outer surface of the flanges 12. Fig. la shows an enlargement of a single flangel2. Alternatively, the main body can have striations 14, wherein a cross-section of the main body 11 would reveal a jagged outer edge as shown in Fig. 3. The striations increase the surface area and preferably also have microstructures on their outer surface. The main body 11 can also be porous.
Still further, Fig. 2 shows a wand 2 having a sample capture assembly 4 that has microstructures 13a associated therewith within it in the form of microparticles enclosed inside a mesh enclosure 13b. The microparticles are made from silica-based material, polystyrene or other synthetic polymers and may be coated with a target specific surface such as specific oligonucleotides, peptides or cell receptors to capture a target DNA, RNA, protein or cell type. They are preferably about 1 to SOO~tm in diameter.
The sample collection assembly 4 may be coated with oligonucleotide probes or specific proteins to capture specific target molecules. The sample collection assembly may also be made of or coated with a material that binds non-specifically with nucleic U.S. Patent Application of IBRAHIM
acids or proteins. A suitable material for binding non-specifically to nucleic acids include silica-based material and synthetic polymers. However, a host of other naturally occurring or chemically modified elements that are known to bind non-specifically to nucleic acids or proteins may be used. The sample collection assembly can also be coated with gold, platimum or other material to enhance electrical or electrochemical conductivity. The sample collection assembly can also be coated with singular or dendritic oligonucleotide probes, peptide probes or cell receptors to capture specific target molecules. The use of dendritic probes in conjunction with the sample collection assembly described herein can further significantly increase the capture surface area and significantly enhance analytical and clinical sensitivity.
The capture of nucleic acids, proteins or cells either non-specifically or by affinity binding onto solid phase supports as well as colorimetric, luminescent, fluorescent and electrochemical detection are well known in the art as described in the following and other references, of which these are herein incorporated by reference: Ausubel F., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., Struhl K., (1987).
Current Protocols in Molecular Biology. Greene Publishing Associates and Wiley-Intersciences.
John Wiley & Sons, New York, Chichester, Brisbane, Toronto, Singapore.;
Sambrook J., Fritsch EF, Maniatis J. ( 1989). Molecular cloning: A laboratory manual. 2"d edition, Cold Spring Harbor laboratory Press, Cold Spring Harbor, New York.; Hornes E., Korsnes L. ( 1990). Magnetic DNA hybridization properties of oligonucleotide probes attached to superparamagnetic beads and their use in the isolation of poly(A) mRNA
from eukaryotic cells. Genet. Anal. Tech. Appl. 7:145-150.; Jakobsen K.S., Haugen M., Saeboe-Larsen S., Hollung K., Espelund M., Hornes E. ( 1994). Direct mRNA
isolation using magnetic Oligo(dT) beads: A protocol for all types oc cell cultures, animal and plant tissues. In: Advances in Biomagnetic Separation, (Ed. Uhlen M., Hornes E., Olsvik O) Eaton Publishing pp.61-71.; Rodriguez LR., Chader G.J. (1992). A novel method for the isolation of tissue specific genes. Nucleic Acids Res. 18:4833-4842.;
Schussler P., Gohr L.G., Sommer G., Kunz W., Grevelding C.G. (1995). Combined isolation of nucleic acids and proteins from small amounts of tissue. Trends Genet. 11:378-379.;
Beattie K.L., Fowler R.F. (1991). Solid-phase gene assembly. Nature 352:548-552.;
Rudi K., Kroken M., Dahlberg O.J., Deggerdal A., Jakobsen K.S., Larsen F. ( 1997).
U.S. Patent Application of IBRAHIM
Rapid, universal method to isolate PCR-ready DNA using magnetic beads.
BioTechniques 22:506-511.; Collin-Osdoby P., Oursler M.J., Webber D., Osdoby P.
( 1991 ). Osteoclast-specific monoclonal antibodies coupled to magnetic beads provide a rapid and efficient method of purifying avian osteoclasts. J. Bone Mine. Res.
6:1353-1365.; Cudjoe K.S., Krona R., Olsen E. (1994). IMS: A new selective enrichment technique for the detection of salmonella in foods. Int. J. Food Microbiol.
23:159-165.;
Elgar G.S., Brenner S. (1992). A novel method for isolation of large insert DNA from recombinant lambda DNA. Nucleic Acids Res. 20:4667.; Gabrielsen O.S., Huet J.
(1993). Magnetic DNA affinity purification of yeast transcription factor.
Meth.
Enzymol. 218:508-525.; Hames B.D., Higgins S.J. (1985). Nucleic acid hybridization:
A practical approach. IRL Press, Oxford, England.; Hawkins R.E., Russell S.J., Winter G. ( 1992). Selection of phage antibodies by binding affinity. Mimicking affinity maturation. J. Mol. Biol. 226:889-896.; Boom, R., Sol, C.J., Salimans, M.M., Jansen, C.L., Wertheim-van Dillen, P.M., and van der Noordaa, J. (1990). Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol., 28(3):495-503.;
Lundeberg J., Larsen F. (1995). Solid-phase technology:magnetic beads to improve nucleic acid detection and analysis. Biotechnology Annual Review 1:373-401.; Millar D.S., Withey S.J., Tizard M.L.V., Ford J.G., Hermon-Taylor J. (1995). Solid-phase hybridization capture of low abundance target DNA sequences: application to the polymerase chain reaction detection of Mycobacterium paratuberculosis and Mycobacterium avium susp.
Silvaticum. Anal. Biochem. 226:325-330.; Vlieger A.M., Medenblik A.M.J.C., Van Gijlswijk R.P.M., Tanke H.J., Van der Ploeg M., Gratama J.W., Raap A.K.
(1992).
Quantitation of polymerase chain reaction products by hybridization-based assays with fluorescent, colorimetric or chemiluminescent detection. Anal. Biochem. 205:1-7.
The reservoir tube 6 serves as a reservoir for collecting samples, washing the captured nucleic acids, proteins, antibodies or antigens, and eluting the captured nucleic acid or proteins or other molecules. The reservoir tube 6 described herein has an elongated body 7 with one end having a lip 10 defining an opening 9 and a second end 8 that is closed and preferably cone shaped. The second end 8 can also be rounded or cylindrical. The cap S of the wand 2 securely and sealingly fastens to the open end 9 of the reservoir tube 6 with the shaft 3 and the sample collection assembly 4 fitting easily U.S. Patent Application of IBRAHIM
inside the reservoir tube 6. The reservoir tube typically holds 0.5-15 ml of sample and preferably is a 1.5 ml reservoir tube. The reservoir tube can be larger or smaller without detracting from the spirit of the invention. The reservoir can also be designed in the form of a microtiter plate or microtiter plate modules to allow arrayable, modular configuration.
The reservoir tube is made of a size to enclose the shaft and sample capture assembly of the wand and sealingly engage the wand's cap. The reservoir and wand can be manufactured together and be packaged as a kit with multiple reservoir (tubes of different sizes and shapes or microtiter plates) in each kit. The wand can be manufactured in a size to fit reservoirs of different sizes and shapes that are commercially sold on the market and commonly used in biomedical research.
In use, a sample is placed inside a first reservoir tube with a lysis or denaturing solution. By the term DNA or RNA sample, it is meant a sample, usually cells, that contain DNA or RNA within the cells. Then the wand is inserted into the first reservoir tube. The cap of the wand secures and seals closed the first reservoir tube.
The first reservoir tube is agitated by shaking or vortexing to mix the sample with the denaturing solution. The first tube is preferably incubated at 37°C for a period of 5-15 minutes. The shaft of the wand can be thermally regulated through an attachment or wire connection 22 to a heating unit 21 as shown in Fig. 6. During this step, the target molecules bind to the massive surface area of the sample collection assembly.
The wand, which now has target molecules bound to the sample collection assembly is then removed from the first reservoir tube and inserted into a second reservoir tube which contains a wash buffer. The second reservoir tube is then securely and sealingly closed with the cap of the wand as before. The second reservoir tube is also agitated to mix the sample with the wash buffer. One or several washes can be performed in the same reservoir if multiple washing is necessary to remove inhibitory material from the captured nucleic acids. The wand is then removed from the second reservoir tube and inserted into a third reservoir tube. The third reservoir tube contains an elution buffer. The third reservoir tube is incubated at about 65°C
for about 5-15 minutes with or without agitation or vortexing (agitation or vortexing may enhance elution). If the shaft is attached to a heating unit that regulates temperature in the sample to U.S. Patent Application of IBRAHIM
capture assembly, elution can be achieved by adjusting the incubation temperature.
After a short while, the DNA or RNA is purified. It can then be recovered and analyzed.
It is also possible to perform thermal cycling while the captured DNA is bound to the capture assembly, and the elution buffer is replaced with the appropriate nucleic acid amplification buffer and reagents.
The sample can be detected by one of several methods. DNA or amplified DNA
can be detected by known colorimetric, luminescent, fluorescent or electrochemical methods.
In another embodiment, the wand may further have a sensing unit 24 associated with it via a sensing contact or wire connection 25 as shown in FIG. 6 for sensing electrical or electrochemical signals emitted from the sample on the sample collection assembly, following a hybridization and/or an enzymatic reaction. Such a sensing unit would detect changes in electrical properties of bound nucleic acids or protein molecules either directly or indirectly. Direct detection can be achieved by measuring changes in current subsequent to a hybridization reaction. Indirect detection can be achieved by including in the hybridization reaction an enzyme and a substrate to drive a reduction/oxidation reaction resulting in electrical current change which can be measured by an electric current sensing device, for example. Alternatively, other indirect reaction may involve enzymatic reaction to produce colorimetric, fluorogenic or luminescence signal which can be detected with miniature optical devices such as a flurometer or spectrometer designed to fit the closed end of the reservoir. In this embodiment, the tube would fit into such a detection device wherein the detection would take place.
The purification apparatus of the invention can be used for efficient purification of nucleic acids, proteins and cells without the need of centrifugation, precipitation or lengthy incubations. It can also be configured to allow nucleic acid amplification and detection by integrating the purification apparatus into an instrument that allows temperature cycling and detection apparati capable of fluorescent, colorimetric, luminescent or electrochemical sensing.
EK~MPLES
Example 1 U.S. Patent Application of IBRAHIM
In a typical nucleic acids purification, mix 10-100 pl of sample with 100 p.l of lysis/denaturing buffer in a 1.5 ml reservoir tube. Insert the shaft and sample capture assembly of the wand into the reservoir tube and close the reservoir tube with the cap.
Vortex the reservoir tube for about 1 minute. Incubate the reservoir tube at 37°C for about 5 minutes. Remove the wand, and insert the wand into a fresh reservoir tube containing 1000 pl of wash buffer. Vortex the reservoir tube for about 1 minute.
Remove the wand and insert it into a fresh reservoir tube containing 100 pl of elution buffer. Heat the reservoir tube to abut 65°C for about 5 minutes. The DNA or RNA is now purified and ready for further analysis or processing.
Example 2 Detection of nucleic acids can be performed in a variety of formats. For example, after the captured nucleic acids are eluted into the reservoir, a biotin- and a digoxigenin-labeled probes can be hybridized, a streptavidin-coated capture assembly is immersed into the reservoir to capture they hybrid complex, then an antibody against digoxigenin is added to bind to the digoxigenin-labeled probe, then an enzyme labeled secondary antibody is added to bind to the primary antibody, then a chemiluminescent or colorimetric substrate is added to drive a colorimetric or luminescent reactions which can then be detected with a colorimeter, photoluminometer or by an electric current measuring device. A number of washing steps must be performed between the addition of reagents in the same or different reservoirs to remove unbound molecules.
These hybridization and detection methods are known in the art.
It is also possible to configure the detection assays so that the captured nucleic on the sample collection assembly is hybridized in situ to a tagged protein-DNA
probe and proceed with the detection according to methods that known in the art.
It is also possible to configure the detection assays so that fluorescently-labeled probes are used for hybridization and detection according to known methods.
Example 3 U.S. Patent Application of IBRAHIM
Mix 10-100 pl of sample with 100 ~tl of lysis/denaturing buffer in a 1.5 ml reservoir tube. Insert the shaft and sample capture assembly (after coating with appropriate antibody) of the wand into the reservoir tube and close the reservoir tube with the cap. Vortex the reservoir tube for about 1 minute. Incubate the reservoir tube at 37°C
for about 5-15 minutes. Remove the wand, and insert the wand into a fresh reservoir tube containing 1000 pl of blocking buffer. Vortex the reservoir tube for about 1 minute.
Incubate at 37°C for about S-15 minutes. Remove the wand and insert it into a fresh reservoir tube containing 100 p.l of conjugate solution. Remove the wand, and insert the wand into a fresh reservoir tube containing 1000 p.l of wash buffer. Shake or agitate for 1 min. Discard wash buffer and repeat the washing step. Remove the wand and insert it into a fresh reservoir tube containing 100 ltl of detection reagent. Analyze the color and determine the antigen according to a color chart. Alternatively, the color can be read by using a spectrophotometer. The detection step can also be modified to allow electrochemical, luminescent or fluorescent detection using an appropriate signal detection attachment.
Example 4 Mix 10-100 ~tl of sample with 100 ~1 of lysis/denaturing buffer in a 1.5 ml reservoir tube. Insert the shaft and sample capture assembly (after coating with appropriate antigen) of the wand into the reservoir tube and close the reservoir tube with the cap. Vortex the reservoir tube for about 1 minute. Incubate the reservoir tube at 37°C
for about 5-15 minutes. Remove the wand, and insert the wand into a fresh reservoir tube containing 1000 pl of blocking buffer. Vortex the reservoir tube for about 1 minute.
Incubate at 37°C for about S minutes. Remove the wand and insert it into a fresh reservoir tube containing 100 ltl of conjugate solution. Remove the wand, and insert the wand into a fresh reservoir tube containing 1000 pl of wash buffer. Discard the wash buffer and repeat the washing step. Remove the wand and insert it into a fresh reservoir tube containing 100 pl of detection reagent. Analyze the color and determine the antibody.
U.S. Patent Application of IBRAHIM
Alternatively, the color can be read by using a spectrophotometer. The detection step can also be modified to allow electrochemical, luminescent or fluorescent detection using an appropriate signal detection attachment.
The present purification apparatus also has applications in detection of blood chemistry, detection of chemokines and other disease markers and identification of microbial agents.
Having thus described in detail preferred embodiments of the present invention, it is to be understood that the invention defined by the appended claims is not to be limited by particular details set forth in the above description as many apparent variations thereof are possible without departing from the spirit or scope of the present invention.
Claims (62)
1. A purification apparatus comprising:
a wand comprising a cap, a sample collection assembly and an elongated shaft connecting said cap to said sample collection assembly, said sample collection assembly having microstructures for increasing the surface area of the sample collection assembly;
and a reservoir tube having a lip defining an opening, wherein said cap securely and sealingly fastens to said lip of said reservoir tube with said shaft and said sample collection assembly inside said reservoir tube.
a wand comprising a cap, a sample collection assembly and an elongated shaft connecting said cap to said sample collection assembly, said sample collection assembly having microstructures for increasing the surface area of the sample collection assembly;
and a reservoir tube having a lip defining an opening, wherein said cap securely and sealingly fastens to said lip of said reservoir tube with said shaft and said sample collection assembly inside said reservoir tube.
2. The purification apparatus of claim 1, wherein said microstructures are selected from the group consisting of cross-etched lanes, dimples, pillars and pores.
3. The purification apparatus of claim l, wherein said sample collection assembly comprises a main body having one or more flanges, wherein said microstructures are on an outer surface thereof for binding target molecules.
4. The purification apparatus of claim 3, wherein said microstructures are selected from the group consisting of cross-etched lanes, dimples, pillars and pores.
5. The purification apparatus of claim l, wherein said sample collection assembly comprises a main body having an outer surface, wherein said microstructures are on said outer surface for binding target molecules.
6. The purification apparatus of claim l, wherein said sample collection assembly comprises a mesh outer surface and wherein said microstructures comprise microparticles enclosed within said mesh outer surface.
7. The purification apparatus of claim l, wherein said sample collection assembly comprises a main body, wherein said main body has a striated outer surface.
8. The purification apparatus of claim 1, wherein said sample collection assembly is coated with oligonucleotide probes or specific proteins or cell receptors to capture specific target molecules, cells or microorganisms.
9. The purification apparatus of claim 1, where said sample collection assembly is coated with gold, platinum or other material to enhance electrical or electrochemical conductivity.
10. The purification apparatus of claim 1, wherein said sample collection assembly is coated with a material that binds non-specifically with nucleic acids or proteins.
11. The purification apparatus of claim 1, wherein said sample collection assembly comprises a material that binds non-specifically with nucleic acids or proteins.
12. The purification apparatus of claim l, wherein said sample collection assembly is made of or coated with a material comprising silicon oxide, aluminum oxide.
13. The purification apparatus of claim 1, wherein said cap is a screw-on cap.
14. The purification apparatus of claim 1, wherein said cap is a snap-on cap.
15. The purification apparatus of claim 14, wherein said cap further comprises a tab for removal of said snap-on cap from said reservoir tube.
16. The purification apparatus of claim 14, wherein said snap-on cap has a stopper lip.
17. The purification apparatus of claim 1, wherein said reservoir tube comprises an elongated body having a lip defining an opening at a first end and a cone or cylindrical shaped second end.
18. The purification apparatus of claim 1, wherein said wand further comprises a heating unit associated with said wand for heating the sample collection assembly.
19. The purification apparatus of claim 1, wherein said wand further comprises a sensing unit associated with said wand for sensing electrical or electrochemical signals through said sample collection assembly.
20. The purification apparatus of claim l, wherein said reservoir has associated therewith a detecting unit comprising an optical device or spectrometer.
21. A purification kit comprising:
packaged in association together, a wand comprising a cap, a sample collection assembly and an elongated shaft connecting said cap to said sample collection assembly, said sample collection assembly having a surface containing microstructures for increasing the surface area of the sample collection assembly; and a plurality of reservoir tubes or microtiter plate modules wherein each of said reservoir tube or module has a lip defining an opening, wherein said cap securely and sealingly fastens to a said lips of said reservoir tubes or modules with said shaft and said sample collection assembly inside said reservoir tube or module.
packaged in association together, a wand comprising a cap, a sample collection assembly and an elongated shaft connecting said cap to said sample collection assembly, said sample collection assembly having a surface containing microstructures for increasing the surface area of the sample collection assembly; and a plurality of reservoir tubes or microtiter plate modules wherein each of said reservoir tube or module has a lip defining an opening, wherein said cap securely and sealingly fastens to a said lips of said reservoir tubes or modules with said shaft and said sample collection assembly inside said reservoir tube or module.
22. The purification kit of claim 21, wherein said microstructures are selected from the group consisting of cross-etched lanes, dimples, pillars and pores.
23. The purification kit of claim 21, wherein said sample collection assembly comprises a main body having an outer surface, wherein said microstructures are on said outer surface for binding target molecules.
24. The purification kit of claim 21, wherein said sample collection assembly comprises a main body having one or more flanges associated therewith, wherein said flanges have microstructures on an outer surface thereof for binding target molecules.
25. The purification kit of claim 24, wherein said microstructures are selected from the group consisting of cross-etched lanes, dimples, pillars and pores.
26. The purification kit of claim 21, wherein said sample collection assembly comprises a mesh outer surface with microparticles enclosed within said mesh outer surface.
27. The purification kit of claim 21, wherein said sample collection assembly is coated with oligonucleotide probes or specific proteins to capture specific target molecules.
28. The purification kit of claim 21, wherein said sample collection assembly is coated with a material that binds non-specifically with nucleic acids or proteins or coated with material to enhance electrical or electrochemical conductivity.
29. The purification kit of claim 21, wherein said sample collection assembly comprises a material that binds non-specifically with nucleic acids or proteins.
30. The purification kit if claim 29, wherein said material is silicon oxide or aluminum oxide.
31. A method of DNA or RNA purification comprising:
placing a DNA or RNA containing sample and a denaturing solution in a first reservoir tube, inserting a wand into said first reservoir tube, wherein said wand comprises a cap, a sample collection assembly and an elongated shaft connecting said cap to said sample collection assembly, said sample collection assembly having microstructures for increasing the surface area of the sample collection assembly;
securely and sealingly closing said first reservoir tube with said cap of said wand with said shaft and said sample collection assembly inside said first reservoir tube;
agitating said first reservoir tube to mix said sample with said denaturing solution, thereby binding said DNA or said RNA to said sample collection assembly;
removing said wand from said first reservoir tube and inserting said wand into a second reservoir tube; said second reservoir tube containing a wash buffer;
securely and sealingly closing said second reservoir tube with said cap of said wand with said shaft and said sample collection assembly inside said second reservoir tube;
agitating said second reservoir tube to mix said sample with said wash buffer;
removing said wand from said second reservoir tube and inserting said wand into a third reservoir tube; said third reservoir tube containing an elution buffer;
incubating said third reservoir tube; and recovering purified DNA or RNA from said third reservoir tube.
placing a DNA or RNA containing sample and a denaturing solution in a first reservoir tube, inserting a wand into said first reservoir tube, wherein said wand comprises a cap, a sample collection assembly and an elongated shaft connecting said cap to said sample collection assembly, said sample collection assembly having microstructures for increasing the surface area of the sample collection assembly;
securely and sealingly closing said first reservoir tube with said cap of said wand with said shaft and said sample collection assembly inside said first reservoir tube;
agitating said first reservoir tube to mix said sample with said denaturing solution, thereby binding said DNA or said RNA to said sample collection assembly;
removing said wand from said first reservoir tube and inserting said wand into a second reservoir tube; said second reservoir tube containing a wash buffer;
securely and sealingly closing said second reservoir tube with said cap of said wand with said shaft and said sample collection assembly inside said second reservoir tube;
agitating said second reservoir tube to mix said sample with said wash buffer;
removing said wand from said second reservoir tube and inserting said wand into a third reservoir tube; said third reservoir tube containing an elution buffer;
incubating said third reservoir tube; and recovering purified DNA or RNA from said third reservoir tube.
32. The method of claim 31, wherein said sample capture assembly comprises a main body having one or more flanges for binding target molecules.
33. The method of claim 32, wherein said flanges further comprises an outer surface having microstructures selected from the group consisting of cross-etched lanes, dimples, pillars and pores.
34. The method of claim 31, wherein said sample collection assembly comprises outer surface having said microstructures, wherein said microstructures are selected from the group consisting of cross-etched lanes, dimples, pillars and pores.
35. The method of claim 31, wherein said sample collection assembly comprises a a mesh outer surface with microparticles enclosed within said mesh outer surface.
36. The method of claim 31, wherein said sample collection assembly is coated with singular or dendritic oligonucleotide or peptide probes to capture specific target molecules.
37. The purification kit of claim 31, wherein said sample collection assembly comprises a material that binds non-specifically with nucleic acids or proteins.
38. The method of claim 31, wherein said sample collection assembly is coated with a material that binds non-specifically with nucleic acids or proteins.
39. The method of claim 38, wherein said material is silicon oxide or aluminum oxide.
40. A method of antigen capture from a sample comprising:
a) placing said sample and a denaturing solution in a first reservoir tube, b) inserting a wand into said first reservoir tube, wherein said wand comprises a cap, a sample collection assembly coated with an antigen specific antibody and an elongated shaft connecting said cap to said sample collection assembly, wherein said sample collection assembly comprises microstructures for increasing the surface area thereof;
c) securely and sealingly closing said first reservoir tube with said cap of said wand with said shaft and said sample collection assembly inside said first reservoir tube;
d) agitating said first reservoir tube to mix said sample with said denaturing solution, thereby binding said antigen to said sample collection assembly;
e) removing said wand from said first reservoir tube and inserting said wand into a second reservoir tube; said second reservoir tube containing a blocking buffer;
f) securely and sealingly closing said second reservoir tube with said cap of said wand with said shaft and said sample collection assembly inside said second reservoir tube;
g) agitating said second reservoir tube to mix said sample with said blocking buffer;
h) removing said wand from said second reservoir tube and inserting said wand into a third reservoir tube; said third reservoir tube containing a conjugate solution;
i.) removing said wand from said third reservoir tube and inserting said wand into a forth reservoir tube; said forth reservoir tube containing a wash buffer and washing several times;
j) capturing said antigen on said coating of said capture assembly.
a) placing said sample and a denaturing solution in a first reservoir tube, b) inserting a wand into said first reservoir tube, wherein said wand comprises a cap, a sample collection assembly coated with an antigen specific antibody and an elongated shaft connecting said cap to said sample collection assembly, wherein said sample collection assembly comprises microstructures for increasing the surface area thereof;
c) securely and sealingly closing said first reservoir tube with said cap of said wand with said shaft and said sample collection assembly inside said first reservoir tube;
d) agitating said first reservoir tube to mix said sample with said denaturing solution, thereby binding said antigen to said sample collection assembly;
e) removing said wand from said first reservoir tube and inserting said wand into a second reservoir tube; said second reservoir tube containing a blocking buffer;
f) securely and sealingly closing said second reservoir tube with said cap of said wand with said shaft and said sample collection assembly inside said second reservoir tube;
g) agitating said second reservoir tube to mix said sample with said blocking buffer;
h) removing said wand from said second reservoir tube and inserting said wand into a third reservoir tube; said third reservoir tube containing a conjugate solution;
i.) removing said wand from said third reservoir tube and inserting said wand into a forth reservoir tube; said forth reservoir tube containing a wash buffer and washing several times;
j) capturing said antigen on said coating of said capture assembly.
41. The method of claim 40, further comprising removing said wand from said forth reservoir tube and inserting in a fifth reservoir tube; said fifth reservoir tube containing a detection agent; and detecting said antigen by a method selected from the group consisting of colorimetric, fluorescent, luminescent and electrochemical methods.
42. The method of claim 40, wherein said microstructures are selected from the group consisting of cross-etched lanes, dimples, pillars and pores.
43. The method of claim 40, wherein said sample collection assembly comprises a main body having an outer surface, wherein said microstructures are on said outer surface for binding target molecules.
44. The method of claim 40, wherein said sample collection assembly comprises a main body having one or more flanges associated therewith, wherein said flanges have microstructures on an outer surface thereof for binding target molecules.
45. The method of claim 44, wherein said microstructures are selected from the group consisting of cross-etched lanes, dimples, pillars and pores.
46. The method of claim 40, wherein said sample collection assembly comprises a mesh outer surface with microparticles enclosed within said mesh outer surface.
47. The method of claim 40, wherein said sample collection assembly is coated with singular or dendritic oligonucleotide, peptide probes or cell receptors to capture specific target molecules.
48. The method of claim 40, wherein said sample collection assembly is coated with a material that binds non-specifically with nucleic acids or proteins.
49. The purification apparatus of claim 40, wherein said sample collection assembly comprises a material that binds non-specifically with nucleic acids or proteins.
50. The purification apparatus if claim 48, wherein said material is made of silicon oxide, aluminum oxide, or other compounds with similar nucleic acids and protein adsorptive properties.
51. A method of antibody capture from a sample comprising:
a) placing said sample and a denaturing solution in a first reservoir tube, b) inserting a wand into said first reservoir tube, wherein said wand comprises a cap, a sample collection assembly coated with specific antigen and an elongated shaft connecting said cap to said sample collection assembly, wherein said sample collection assembly comprises microstructures for increasing surface area thereof;
c) securely and sealingly closing said first reservoir tube with said cap of said wand with said shaft and said sample collection assembly inside said first reservoir tube;
d) agitating said first reservoir tube to mix said sample with said denaturing solution, thereby binding said antibody to said sample collection assembly;
e) removing said wand from said first reservoir tube and inserting said wand into a second reservoir tube; said second reservoir tube containing a blocking buffer;
f) securely and sealingly closing said second reservoir tube with said cap of said wand with said sample collection assembly inside said second reservoir tube;
g) agitating said second reservoir tube to mix said sample with said blocking buffer;
h) removing said wand from said second reservoir tube and inserting said wand into a third reservoir tube; said third reservoir tube containing a conjugate solution;
i) removing said wand from said third reservoir tube and inserting said wand into a forth reservoir tube; said forth reservoir tube containing a wash buffer and washing several times; and j) capturing said antibody on said coating of said capture assembly.
a) placing said sample and a denaturing solution in a first reservoir tube, b) inserting a wand into said first reservoir tube, wherein said wand comprises a cap, a sample collection assembly coated with specific antigen and an elongated shaft connecting said cap to said sample collection assembly, wherein said sample collection assembly comprises microstructures for increasing surface area thereof;
c) securely and sealingly closing said first reservoir tube with said cap of said wand with said shaft and said sample collection assembly inside said first reservoir tube;
d) agitating said first reservoir tube to mix said sample with said denaturing solution, thereby binding said antibody to said sample collection assembly;
e) removing said wand from said first reservoir tube and inserting said wand into a second reservoir tube; said second reservoir tube containing a blocking buffer;
f) securely and sealingly closing said second reservoir tube with said cap of said wand with said sample collection assembly inside said second reservoir tube;
g) agitating said second reservoir tube to mix said sample with said blocking buffer;
h) removing said wand from said second reservoir tube and inserting said wand into a third reservoir tube; said third reservoir tube containing a conjugate solution;
i) removing said wand from said third reservoir tube and inserting said wand into a forth reservoir tube; said forth reservoir tube containing a wash buffer and washing several times; and j) capturing said antibody on said coating of said capture assembly.
52. The method of claim 51, further comprising removing said wand from said forth reservoir tube and inserting it into a fifth reservoir tube; said fifth reservoir tube containing a detection agent; and detecting said antibody by fluorescent, colorimetric, luminescent or electrochemical methods.
53. The method of claim 51, wherein said microstructures are selected from the group consisting of cross-etched lanes, dimples, pillars and pores.
54. The method of claim 51, wherein said sample collection assembly comprises a main body having an outer surface, wherein said microstructures are on said outer surface for binding target molecules.
55. The method of claim 51, wherein said sample collection assembly comprises a main body having one or more flanges associated therewith, wherein said flanges have microstructures on an outer surface thereof for binding target molecules.
56. The method of claim 55, wherein said microstructures are selected from the group consisting of cross-etched lanes, dimples, pillars and pores.
57. The method of claim 51, wherein said sample collection assembly comprises a mesh outer surface with microparticles enclosed within said mesh outer surface.
58. The method of claim 51, wherein said sample collection assembly is coated with oligonucleotide probes or specific proteins to capture specific target molecules.
59. The method of claim 51, wherein said sample collection assembly is coated with a material that binds non-specifically with nucleic acids or proteins.
60. The method of claim 5l, wherein said sample collection assembly comprises a material that binds non-specifically with nucleic acids or proteins.
61. The method of claim 59, wherein said material is silicon oxide or aluminum oxide.
62. A purification wand for fitting into a plastic tube or microtiter plate module comprising:
a sample collection assembly and an elongated shaft connecting said cap to said sample collection assembly, said sample collection assembly having microstructures for increasing the surface area of the sample collection assembly.
a sample collection assembly and an elongated shaft connecting said cap to said sample collection assembly, said sample collection assembly having microstructures for increasing the surface area of the sample collection assembly.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10943798P | 1998-11-23 | 1998-11-23 | |
| US60/109,437 | 1998-11-23 | ||
| PCT/US1999/027741 WO2000030753A1 (en) | 1998-11-23 | 1999-11-22 | Purification method and apparatus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2351616A1 true CA2351616A1 (en) | 2000-06-02 |
Family
ID=22327650
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002351616A Abandoned CA2351616A1 (en) | 1998-11-23 | 1999-11-22 | Purification method and apparatus |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US6919200B2 (en) |
| EP (1) | EP1159071B1 (en) |
| AT (1) | ATE317297T1 (en) |
| AU (1) | AU764964B2 (en) |
| CA (1) | CA2351616A1 (en) |
| DE (1) | DE69929826D1 (en) |
| WO (1) | WO2000030753A1 (en) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9425138D0 (en) | 1994-12-12 | 1995-02-08 | Dynal As | Isolation of nucleic acid |
| US20080260593A1 (en) * | 2000-03-22 | 2008-10-23 | Dewalch Norman Binz | Method and apparatus for processing substances in a single container |
| AU2002345746A1 (en) * | 2001-06-21 | 2003-01-08 | The Regents Of The University Of California | Electrochemical detection of mismatch nucleic acids |
| CN1617938A (en) * | 2002-01-16 | 2005-05-18 | 戴诺生物技术有限公司 | Method for isolating nucleic acids and protein from a single sample |
| JP5686493B2 (en) | 2003-01-24 | 2015-03-18 | ユニバーシティ・オブ・ユタＵｎｉｖｅｒｓｉｔｙ Ｏｆ Ｕｔａｈ | How to predict the risk of death by determining telomere length |
| US7087437B2 (en) | 2003-09-16 | 2006-08-08 | Vici Gig Harbor Group, Inc. | Direct vial surface sorbent micro extraction device and method |
| WO2005028635A2 (en) * | 2003-09-19 | 2005-03-31 | Microfluidic Systems Inc. | Microfluidic differential extraction cartridge |
| US7541166B2 (en) * | 2003-09-19 | 2009-06-02 | Microfluidic Systems, Inc. | Sonication to selectively lyse different cell types |
| US8053214B2 (en) * | 2004-09-09 | 2011-11-08 | Microfluidic Systems, Inc. | Apparatus and method of extracting and optically analyzing an analyte from a fluid-based sample |
| US7988935B2 (en) * | 2004-09-09 | 2011-08-02 | Microfluidic Systems, Inc. | Handheld and portable microfluidic device to automatically prepare nucleic acids for analysis |
| US7785868B2 (en) * | 2004-12-02 | 2010-08-31 | Microfluidic Systems, Inc. | Apparatus to automatically lyse a sample |
| KR100699862B1 (en) * | 2005-08-26 | 2007-03-27 | 삼성전자주식회사 | Dual reference input receiver of semiconductor device and method for receiving input data signal |
| US8703445B2 (en) | 2005-12-29 | 2014-04-22 | Abbott Point Of Care Inc. | Molecular diagnostics amplification system and methods |
| US20080050724A1 (en) * | 2006-08-24 | 2008-02-28 | Microfluidic Systems, Inc. | Method of detecting one or more limited copy targets |
| US7633606B2 (en) * | 2006-08-24 | 2009-12-15 | Microfluidic Systems, Inc. | Integrated airborne substance collection and detection system |
| US7705739B2 (en) * | 2006-08-24 | 2010-04-27 | Microfluidic Systems, Inc. | Integrated airborne substance collection and detection system |
| US7858366B2 (en) * | 2006-08-24 | 2010-12-28 | Microfluidic Systems, Inc | Integrated airborne substance collection and detection system |
| US8357296B2 (en) | 2007-09-24 | 2013-01-22 | Emd Millipore Corporation | Centrifugal filter |
| US20090137024A1 (en) * | 2007-11-28 | 2009-05-28 | Canon U.S. Life Sciences, Inc. | Method of Separating Target DNA from Mixed DNA |
| US8133451B2 (en) * | 2008-08-28 | 2012-03-13 | Microfluidic Systems, Inc. | Sample preparation apparatus |
| CN107083444B (en) | 2008-12-22 | 2023-03-14 | 犹他大学研究基金会 | Monochromatic multiplex quantitative PCR |
| US20130078641A1 (en) * | 2010-06-01 | 2013-03-28 | Streck, Inc. | Sample processing method and device |
| US9304070B2 (en) | 2011-07-13 | 2016-04-05 | Emd Millipore Corporation | All-in-one sample preparation device and method |
| US20140370505A1 (en) * | 2011-12-31 | 2014-12-18 | Telome Health, Inc. | Saliva-derived measures of telomere abundance and sample collection device |
| JP6198754B2 (en) * | 2012-02-17 | 2017-09-20 | アルクレスタ， インコーポレイテッド | Methods, compositions, and devices for meeting dietary fatty acid requirements |
| US8850830B2 (en) | 2012-06-12 | 2014-10-07 | Hamilton Sundstrand Corporation | Temperature compensation system and method |
| EP2999800B1 (en) | 2013-05-22 | 2019-09-25 | Telomere Diagnostics Inc. | Measures of short telomere abundance |
| EP3003561B1 (en) * | 2013-05-24 | 2018-12-19 | Occam Biolabs, Inc. | System and method for collecting a sample of nucleic acid |
| WO2016081860A1 (en) | 2014-11-21 | 2016-05-26 | Occam Biolabs, Inc. | System and method for collecting a sample of nucleic acid |
| US9944978B2 (en) | 2014-12-30 | 2018-04-17 | Telomere Diagnostics, Inc. | Multiplex quantitative PCR |
| WO2017027643A1 (en) | 2015-08-10 | 2017-02-16 | Essenlix Corp. | Bio/chemical assay devices and methods for simplified steps, small samples, accelerated speed, and ease-of-use |
| WO2017048871A1 (en) | 2015-09-14 | 2017-03-23 | Essenlix Corp. | Device and system for analyzing a sample, particularly blood, as well as methods of using the same |
| CA2998635C (en) | 2015-09-14 | 2021-08-24 | Essenlix Corporation | Device and system for collecting and analyzing vapor condensate, particularly exhaled breath condensate, as well as method of using the same |
| JP6667052B1 (en) | 2016-12-21 | 2020-03-18 | エッセンリックス コーポレーション | Device and method for authenticating a sample and use thereof |
| WO2018148342A1 (en) | 2017-02-07 | 2018-08-16 | Essenlix Corporation | Compressed open flow assay and use |
| WO2018148469A1 (en) | 2017-02-08 | 2018-08-16 | Essenlix Corp. | Bio/chemical material extraction and assay |
| CA3053132A1 (en) | 2017-02-09 | 2018-08-16 | Essenlix Corp. | Assay with amplification |
| JP7004732B2 (en) | 2017-02-09 | 2022-01-21 | エッセンリックス コーポレーション | Assay method using different spacing heights |
| JP2020507770A (en) | 2017-02-09 | 2020-03-12 | エッセンリックス コーポレーション | Colorimetric assay |
| JP7107953B2 (en) | 2017-02-16 | 2022-07-27 | エッセンリックス コーポレーション | Assays using textured surfaces |
| US20180312924A1 (en) * | 2017-04-26 | 2018-11-01 | Michael Joseph Pugia | Protein and gene analysis from same sample |
| CN111492222A (en) | 2017-08-01 | 2020-08-04 | Essenlix公司 | Sample collection, retention and assay |
| US11280706B2 (en) | 2017-08-01 | 2022-03-22 | Essenlix Corporation | Dilution calibration |
| WO2019028133A1 (en) | 2017-08-01 | 2019-02-07 | Essenlix Corporation | Devices and methods for examining drug effects on microorganisms |
| WO2019075415A1 (en) | 2017-10-13 | 2019-04-18 | Essenlix Corporation | Devices and methods for authenticating a medical test and use of the same |
| US11609224B2 (en) | 2017-10-26 | 2023-03-21 | Essenlix Corporation | Devices and methods for white blood cell analyses |
| US11237113B2 (en) | 2017-10-26 | 2022-02-01 | Essenlix Corporation | Rapid pH measurement |
| US10807095B2 (en) | 2017-10-26 | 2020-10-20 | Essenlix Corporation | Making and tracking assay card |
| WO2019118652A1 (en) | 2017-12-12 | 2019-06-20 | Essenlix Corporation | Sample manipulation and assay with rapid temperature change |
| CN112534259A (en) | 2017-12-14 | 2021-03-19 | Essenlix公司 | Device, system and method for monitoring hair |
| US11156606B2 (en) | 2018-01-11 | 2021-10-26 | Essenlix Corporation | Homogeneous assay (II) |
| US11885952B2 (en) | 2018-07-30 | 2024-01-30 | Essenlix Corporation | Optics, device, and system for assaying and imaging |
| CN116194753A (en) * | 2020-07-13 | 2023-05-30 | 3M创新有限公司 | Kit and method for using combined samples to increase sensitivity |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4225575A (en) * | 1978-05-15 | 1980-09-30 | Ventrex Laboratories, Inc. | Method and apparatus for performing in vitro clinical diagnostic tests using a solid phase assay system |
| US4657869A (en) * | 1984-05-18 | 1987-04-14 | E. I. Du Pont De Nemours And Company | Self-contained device for carrying out specific binding assays |
| US4789628A (en) | 1986-06-16 | 1988-12-06 | Vxr, Inc. | Devices for carrying out ligand/anti-ligand assays, methods of using such devices and diagnostic reagents and kits incorporating such devices |
| US5962218A (en) | 1988-11-03 | 1999-10-05 | Igen International Inc. | Methods and apparatus for improved luminescence assays |
| US5229297A (en) * | 1989-02-03 | 1993-07-20 | Eastman Kodak Company | Containment cuvette for PCR and method of use |
| DE69032425T2 (en) * | 1990-05-11 | 1998-11-26 | Microprobe Corp | Immersion test strips for nucleic acid hybridization assays and methods for covalently immobilizing oligonucleotides |
| US5173260A (en) * | 1990-09-17 | 1992-12-22 | Eastman Kodak Company | Beads fused to a test device support |
| DE4034036C2 (en) * | 1990-10-26 | 1994-03-03 | Diagen Inst Molekularbio | Device and method for isolating nucleic acids from cell suspensions |
| US5665582A (en) | 1990-10-29 | 1997-09-09 | Dekalb Genetics Corp. | Isolation of biological materials |
| ATE189831T1 (en) * | 1991-11-14 | 2000-03-15 | Dgi Inc | NON-RADIOACTIVE HYBRIDIZATION TEST METHOD AND KIT |
| US6022748A (en) * | 1997-08-29 | 2000-02-08 | Sandia Corporation - New Mexico Regents Of The University Of California | Sol-gel matrices for direct colorimetric detection of analytes |
| US5591841A (en) * | 1993-01-14 | 1997-01-07 | Ji; Huamin | Rapid purification of circular DNA by triplex-mediated affinity capture |
| FI930440A0 (en) | 1993-02-01 | 1993-02-01 | Labsystems Oy | BESTAEMNINGSFOERFARANDE |
| US5388588A (en) * | 1993-05-04 | 1995-02-14 | Nabai; Hossein | Biopsy wound closure device and method |
| JP2565097B2 (en) * | 1993-07-09 | 1996-12-18 | 日本電気株式会社 | Subtitles super transmission system |
| US5637687A (en) * | 1993-08-31 | 1997-06-10 | Wiggins; James C. | Methods and compositions for isolating nucleic acids |
| AU1602295A (en) * | 1994-01-14 | 1995-08-01 | Jockey Club, The | Non-invasive sampling method for nucleic acid analysis |
| JPH07308184A (en) * | 1994-05-16 | 1995-11-28 | Nippon Millipore Kk | Device for simply detecting resistant microorganism |
| US5556752A (en) * | 1994-10-24 | 1996-09-17 | Affymetrix, Inc. | Surface-bound, unimolecular, double-stranded DNA |
| JPH08178926A (en) * | 1994-10-25 | 1996-07-12 | Sumitomo Pharmaceut Co Ltd | Immunoassay plate and use thereof |
| US5830154A (en) * | 1996-01-11 | 1998-11-03 | Epitope, Inc. | Device for collecting substances for testing |
| EP1005479A4 (en) * | 1997-04-10 | 2002-12-18 | Life Technologies Inc | Rna isolation reagent and methods |
-
1999
- 1999-11-22 AT AT99961769T patent/ATE317297T1/en not_active IP Right Cessation
- 1999-11-22 CA CA002351616A patent/CA2351616A1/en not_active Abandoned
- 1999-11-22 DE DE69929826T patent/DE69929826D1/en not_active Expired - Lifetime
- 1999-11-22 WO PCT/US1999/027741 patent/WO2000030753A1/en active IP Right Grant
- 1999-11-22 US US09/444,095 patent/US6919200B2/en not_active Expired - Fee Related
- 1999-11-22 AU AU18284/00A patent/AU764964B2/en not_active Ceased
- 1999-11-22 EP EP99961769A patent/EP1159071B1/en not_active Expired - Lifetime
-
2005
- 2005-06-02 US US11/142,959 patent/US7862773B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU764964B2 (en) | 2003-09-04 |
| US6919200B2 (en) | 2005-07-19 |
| ATE317297T1 (en) | 2006-02-15 |
| EP1159071B1 (en) | 2006-02-08 |
| DE69929826D1 (en) | 2006-04-20 |
| US20010036630A1 (en) | 2001-11-01 |
| WO2000030753A1 (en) | 2000-06-02 |
| AU1828400A (en) | 2000-06-13 |
| US7862773B2 (en) | 2011-01-04 |
| EP1159071A1 (en) | 2001-12-05 |
| US20050221377A1 (en) | 2005-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7862773B2 (en) | Purification apparatus | |
| US7119194B2 (en) | Nucleic acid-bondable magnetic carrier and method for isolating nucleic acid using the same | |
| EP0672189B1 (en) | A method of processing nucleic acid samples | |
| US20210292745A1 (en) | Sample preparation method and apparatus | |
| US20180010169A1 (en) | Methods and reagents for selection of biological molecules | |
| EP1260595A2 (en) | Nucleic acid-bondable magnetic carrier and method for isolating nucleic acid using the same | |
| US20030203491A1 (en) | Gravitational flow purification system | |
| JP2002504232A (en) | Method and apparatus for isolating and / or analyzing charged biomolecules | |
| CN109295169A (en) | A kind of microRNA-7a electrochemical detection method and application based on bio-barcode | |
| US10927366B2 (en) | System and method for sequestering substances in bulk liquids | |
| EP2217729B1 (en) | Process for concentrating nucleic acid molecules | |
| WO2001053817A3 (en) | Methods of and apparatus for separating and detecting nucleic acid | |
| JP5007920B2 (en) | Nucleic acid extraction method, cancer cell detection method and magnetic beads | |
| Sugishita et al. | A centrifugation-based method for high-throughput biomaterial separation using magnetic microbeads | |
| KR20200042511A (en) | Method and apparatus for analyzing nucleic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |